PR-018: An Open-Label, Safety Extension of Study PR-011

Summary

A study to evaluate long term safety and effect on ability to thrive of EUR-1008 (APT-1008) 3,000 lipase units (Zenpep® \[pancrelipase\] delayed release capsules) in infants with exocrine pancreatic insufficiency (EPI) due to cystic fibrosis (CF).

Timeline

Start

2010-07

Primary completion

2011-12

Completion

2011-12

Drugs

Indications